Free Trial

Global Opportunities Trust (GOT) Competitors

Global Opportunities Trust logo
GBX 277
+1.00 (+0.36%)
(As of 11/1/2024 ET)

GOT vs. BIOG, PCFC, LIO, JPS, CTPE, WPCT, BGEU, CGL, GSF, and BGHS

Should you be buying Global Opportunities Trust stock or one of its competitors? The main competitors of Global Opportunities Trust include The Biotech Growth Trust (BIOG), Polar Capital Global Financials Trust (PCFC), Liontrust Asset Management (LIO), JPMorgan Japan Small Cap Growth & Income plc (JPS.L) (JPS), CT Private Equity Trust (CTPE), Woodford Patient Capital Trust (WPCT), Baillie Gifford European Growth Trust (BGEU), Castelnau Group (CGL), Gore Street Energy Storage Fund (GSF), and Boussard & Gavaudan GBP (BGHS). These companies are all part of the "asset management" industry.

Global Opportunities Trust vs.

The Biotech Growth Trust (LON:BIOG) and Global Opportunities Trust (LON:GOT) are both small-cap financial services companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking.

The Biotech Growth Trust has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, Global Opportunities Trust has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500.

The Biotech Growth Trust received 6 more outperform votes than Global Opportunities Trust when rated by MarketBeat users. Likewise, 64.06% of users gave The Biotech Growth Trust an outperform vote while only 63.87% of users gave Global Opportunities Trust an outperform vote.

CompanyUnderperformOutperform
The Biotech Growth TrustOutperform Votes
82
64.06%
Underperform Votes
46
35.94%
Global Opportunities TrustOutperform Votes
76
63.87%
Underperform Votes
43
36.13%

The Biotech Growth Trust has a net margin of 92.85% compared to Global Opportunities Trust's net margin of 83.86%. The Biotech Growth Trust's return on equity of 21.57% beat Global Opportunities Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
The Biotech Growth Trust92.85% 21.57% 12.39%
Global Opportunities Trust 83.86%5.17%3.41%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Biotech Growth Trust
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Global Opportunities Trust
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Global Opportunities Trust had 2 more articles in the media than The Biotech Growth Trust. MarketBeat recorded 3 mentions for Global Opportunities Trust and 1 mentions for The Biotech Growth Trust. Global Opportunities Trust's average media sentiment score of 1.68 beat The Biotech Growth Trust's score of 0.89 indicating that Global Opportunities Trust is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Biotech Growth Trust
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Global Opportunities Trust
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

The Biotech Growth Trust has higher revenue and earnings than Global Opportunities Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Global Opportunities Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Biotech Growth Trust£80.35M3.98£74.60M£2.07481.16
Global Opportunities Trust£6.53M12.40£5.48M£0.191,457.89

28.6% of The Biotech Growth Trust shares are owned by institutional investors. Comparatively, 25.6% of Global Opportunities Trust shares are owned by institutional investors. 0.7% of The Biotech Growth Trust shares are owned by company insiders. Comparatively, 38.9% of Global Opportunities Trust shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

The Biotech Growth Trust beats Global Opportunities Trust on 10 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GOT vs. The Competition

MetricGlobal Opportunities TrustAsset Management IndustryFinancial SectorLON Exchange
Market Cap£80.94M£888.77M£3.41B£1.59B
Dividend Yield1.72%13.28%4.49%11.05%
P/E Ratio1,457.89786.02412.891,740.37
Price / Sales12.4014,471.342,692.95230,520.65
Price / Cash2.8389.8550.5735.87
Price / Book0.751.221.392.88
Net Income£5.48M£59.60M£348.49M£144.83M
7 Day Performance-4.15%-0.61%-0.55%0.11%
1 Month Performance-5.14%-1.08%-0.56%-0.11%
1 Year Performance-8.88%12.71%17.27%15.28%

Global Opportunities Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GOT
Global Opportunities Trust
N/AGBX 277
+0.4%
N/A-6.4%£80.94M£6.53M1,457.891Insider Buying
News Coverage
Positive News
BIOG
The Biotech Growth Trust
N/AGBX 1,000.70
-1.1%
N/A+35.1%£321.53M£80.35M483.43N/A
PCFC
Polar Capital Global Financials Trust
N/AGBX 103.50
-0.5%
N/A+0.0%£315.13M£70.33M2.09N/A
LIO
Liontrust Asset Management
1.8874 of 5 stars
GBX 485
-3.0%
GBX 703.33
+45.0%
-11.1%£309.96M£197.89M-9,700.00241
JPS
JPMorgan Japan Small Cap Growth & Income plc (JPS.L)
N/AN/AN/A+0.0%£305.80M£-1,017,000.00-48.36N/APositive News
CTPE
CT Private Equity Trust
N/AGBX 427
+1.7%
N/A-4.8%£305.31M£28.62M2,247.37N/ADividend Announcement
Positive News
High Trading Volume
WPCT
Woodford Patient Capital Trust
N/AGBX 33.60
-2.0%
N/A+0.0%£305.30M£56.03M5.33N/ANews Coverage
BGEU
Baillie Gifford European Growth Trust
N/AGBX 86.30
-1.0%
N/A+13.7%£304.98M£27.20M1,232.86N/ADividend Cut
CGL
Castelnau Group
N/AGBX 94.50
-2.1%
N/A+25.5%£301.81M£1.99M-3,150.00N/A
GSF
Gore Street Energy Storage Fund
N/AGBX 59.63
-1.1%
GBX 85
+42.5%
-14.8%£301.19M£2.27M-5,963.00N/A
BGHS
Boussard & Gavaudan GBP
N/AGBX 2,420
+9,900.0%
N/AN/A£300.90M£-12,390,000.00-1,890.63N/AGap Up

Related Companies and Tools


This page (LON:GOT) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners